Opioid Use Disorder Market

1. Opioid Use Disorder Market: Introduction Opioids are used for pain relief. They have a depressant effect on the central nervous system as well as the potential to cause euphoria. Opioid use disorder (OUD) can occur, due to misuse or overdose of prescribed opioid medications.  Two types of patients suffer from OUD: patients who are addicted to non-medical opioids and patients addicted to medical opioids  Most commonly abused opioids are codeine, oxycodone, hydrocodone, morphine, and fentanyl. Physical dependence is the most harmful long-term effect and withdrawal symptoms occur if opioid use is abruptly reduced. Current treatments are based on medication-assisted treatment (MAT) with an opioid agonist or an opioid antagonist. They involve use of medication along with counseling and behavioral therapies.   Report Overview:https://www.transparencymarketresearch.com/opioid-use-disorder- market.html Key Drivers and Restraints of Global Opioid Use Disorder Market Increasing incidence of opioid use disorder is a major factor likely to drive the global market during the forecast period. According to American Psychiatric Association, in 2017, around 72,000 people in the U.S. died of overdose of drugs, which included illicit drugs and prescription opioids. According to the Center for Disease Control and Prevention (CDC), over 15,000 people in the U.S. died of heroin overdose in 2017.  Increasing research and development activities and wide product pipeline are other factors estimated to fuel the global opioid use disorder market during the forecast period. For instance, Orexo AB, a major manufacturer of opioid use disorder treatment products, has introduced an innovative product in its pipeline i.e. OXD01.  Lack of awareness and limited product availability are restraining the global opioid use disorder market  Buprenorphine Drugs to Witness High Demand Based on drug type, the global opioid use disorder market can be segmented into buprenorphine, methadone, and naltrexone  The buprenorphine segment accounted for the maximum share of the global opioid use disorder market in 2018. The segment is expected to dominate the global market from 2019 to 2027, due to increasing demand for buprenorphine-containing products such as bunavail, sublocade, suboxone, and zubsolv. Suboxone is the most widely prescribed drug for treatment of opioid use disorder, due to its high efficacy in managing opioid addiction, low adverse effect, and its favorable formulary coverage. 

2. Hospital Pharmacies to be Most Promising Segment In terms of distribution channel, the global opioid use disorder market can be divided into hospital pharmacies, retail pharmacies, and online sales. The hospital pharmacies segment generated the maximum revenue in 2018 and it is anticipated to witness significant growth during the forecast period. A majority of opioid use disorder treatment products are prescription products and they are mostly available in hospital pharmacies.  North America to Dominate Global Opioid Use Disorder Market In terms of region, the global opioid use disorder market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa  North America dominated the global opioid use disorder market in 2018 and it is expected to maintain its leading position throughout the forecast period. Dominance of the region can be attributed to expansion of product offerings by market players, favorable government initiatives, and presence of key market players in the region. For instance, in January 2018, the U.S. Government launched an awareness campaign to combat opioid addiction.  The market in Asia Pacific is projected to register the maximum growth rate during the forecast period, owing to increase in the adoption of new products and rise in the incidence of opioid use disorder  Request https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75167 Brochure: Key Manufacturers Operating in Global Market The global opioid use disorder market was highly fragmented in 2018. Major manufacturers operating in the global market are: Indivior PLC  Alkermes  Teva Pharmaceutical Industries Ltd.  MediciNova, Inc.  Hikma Pharmaceuticals  Orexo AB  Camurus AB  Omeros Corporation 

3. About Us Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real- time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision. Contact Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/